Journals / Journal of Basic and Clinical Health Sciences / 2023 / Cilt: 7 - Sayı: 1

Institutional Accuracy Matters: How the Correlation between Frozen Section and Final Pathology Depends on Institutes while Evaluating Lymph Node Involvement in Endometrial Adenocarcinoma

Pages
293–300
Publication Date
2023-01-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, the frozen section analysis had an accuracy of 70% for tumor grades.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Purpose: The frozen section analysis results help determine the appropriate surgery and treatment for patients with endometrial adenocarcinoma.
📊
Key Findings & Data:Methods: This study included 357 patients with endometrial adenocarcinoma who underwent operation, follow-up, and treatment at our hospital.
💡
Conclusion & Impact:Overall, the frozen section analysis had an accuracy of 70% for tumor grades.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Endometrial cancer · neoplasm · tumor staging

Abstract

Background and Purpose: The frozen section analysis results help determine the appropriate surgery and treatment for patients with endometrial adenocarcinoma. This study investigates the degree of compliance between the results of frozen section analysis and final pathology reports in patients with endometrial cancer. Methods: This study included 357 patients with endometrial adenocarcinoma who underwent operation, follow-up, and treatment at our hospital. The patients’ demographic, clinical, surgical, and pathological data were retrospectively analyzed. We compared the results of the frozen section and pathological specimens in terms of final pathology, tumor grade, myometrial invasion, tumor size, and lymphovascular system involvement (LVSI). Results: The frozen section analysis and final pathology results for tumor size and LVSI were significantly correlated when patients were divided by tumor type (tumor size: P=0.006, LVSI: P=0.024) or by risk for lymph node involvement (P=0.000). Overall, the frozen section analysis had an accuracy of 70% for tumor grades. The histological results of the frozen section analysis had an accuracy of 77.1% for type 1 tumors and 72.7% for type 2 tumors. Overall, the frozen section analysis had an accuracy of 95% for myometrial invasion. Conclusion: Intraoperative frozen section analysis can prevent unnecessary lymph node dissection when performed at qualified institutions.

🔖

Cite This Article

YILMAZ, A., GULBAHAR, A. (2023). Institutional Accuracy Matters: How the Correlation between Frozen Section and Final Pathology Depends on Institutes while Evaluating Lymph Node Involvement in Endometrial Adenocarcinoma. Journal of Basic and Clinical Health Sciences, Cilt: 7 - Sayı: 1, 293–300. https://ajindex.com/articles/879833

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. https://gco.iarc.fr/today/online-analysis-dual-bars-2?v=2020&mode=cancer&mode_population=regions&population=250&populations=250&key=asr&sex=2&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=0&include_nmsc_other=1&dual_distribution=1&population1=250&population2=554&show_values=false&type_multiple=%257B%2522inc%2522%253Atrue%252C%2522mort%2522%253Atrue%252C%2522prev%2522%253Afalse%257D&type_sort=0 [accessed: 12.04.2022]
  2. Wang X, Zhang H, Di W, Li W. Clinical factors affecting the diagnostic accuracy of assessing dilation and curettage vs. frozen section specimens for histologic grade and depth of myometrial invasion in endometrial carcinoma Am J Obstet Gynecol 2009;201:194.e1-10. doi:10.1016/j.ajog.2009.05.003 Kilgore LC, Partridge EE, Alvarez RD, et al. adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:29-33. DOI: 10.1006/gyno.1995.1005. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103-4. DOI: 10.1016/j.ijgo.2009.02.012. https://www.uptodate.com/contents/adjuvant-treatment-of-high-risk-endometrial-cancers?csi=09897c32-5592-4353-a77a-689c66dc83b3&source=contentShae [accessed: 12.04.2022]
  3. Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment, and Follow-up. Int J Gynecol Cancer 2016;26:2-30. DOI: 10.1093/annonc/mdv484 Chu CS, Lin L, Rubin SC. Cancer of the uterine body. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 8th ed. DeVita VT, LawrenceTS, Rosenberg SA, editors. Philadelphia, PA: Wolters Kluwer/ Lippincott Williams and Wilkins; 2008:1543-63.
  4. Soliman PT, Frumovitz M, Spannuth W, et al. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010;119(2):291-294. DOI: 10.1016/j.ygyno.2010.07.011 Burke WM, Orr J, Leitao M, et al. Endometrial cancer: a review and current management strategies: part II. Gynecol Oncol. 2014;134(2):393-402. DOI: 10.1016/j.ygyno.2014.06.003 Dowdy SC, Borah BJ, Bakkum-Gamez JN, et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol. 2012;127(1):5-10. DOI: 10.1016/j.ygyno.2012.06.035 Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-